Cancer Bioinformatics Services (CBS) Cancer Bioinformatics Service (CBS) focuses on providing UPCI investigators with the analysis expertise, computational infrastructure, specialized databases and research analytics to support cancer biomarker discovery. These state-of-the-art bioinformatics capabilities involve deep collaborations between the Cancer Bioinformatics Service (CBS) and the Department of Biomedical Informatics bioinformatics faculty, the Pittsburgh Supercomputing Center, the Institute of Personalized Medicine and the University of Pittsburgh?s Simulation and Modeling Center.
The aims of CBS for the next renewal period are to: 1) Provide bioinformatics analysis support for all microarray and Next Generation Sequencing (NGS) platforms. This includes experimental design, differential expression (DE) analysis, miRNA target analysis, copy number analysis, queries of public databases and advanced pathway analysis using commercial (Ingenuity Pathway analysis, GeneGo, and academic (e.g. Cytoscape) tools. 2) Perform integrative analysis of TCGA and other consortia data from all platforms including expression, methylation, somatic variants and copy number. 3) Develop and implement, under a common Data Use Agreement (DUA), the Pittsburgh Genome Resource Repository (PGRR), an infrastructure for storage, analysis and archiving of large petabyte size genomic data such as from The Cancer Genome Atlas (TCGA) project. CBS will also develop PGRR informational sessions and also develop bioinformatics services to facilitate use. 4) Develop specialized databases for programs such as UPCI Skin SPORE that integrate disparate clinical data sources, enabling integration of genomics biomarker data with clinical phenotypes using the open source Informatics for Integrating Biology to the Bedside (i2b2) platforms and related technologies. 5) Provide IT support for the Cancer Genomics Facility (CGF) high performance computing needs, 6) Prepare data for publication including submitting data to the Gene Expression Omnibus (GEO) and assist with manuscript preparation, and 7) Collaborate with the Health Sciences Library System (HSLS) to evaluate bioinformatics tools for licensing and teach quarterly bioinformatics courses to the user community. The goal of CBS is to provide cost effective and efficient bioinformatics analysis services to the UPCI CCSG community. The current proposal focuses on expanding these services as they are critical to the scientific discovery of new cancer biomarkers and therapeutic targets. During that current project period all 10 Research Programs used CBS services.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA047904-28
Application #
9114518
Study Section
Subcommittee A - Cancer Centers (NCI-A)
Project Start
Project End
Budget Start
2016-08-01
Budget End
2017-07-31
Support Year
28
Fiscal Year
2016
Total Cost
$341,805
Indirect Cost
$119,854
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Zahorchak, Alan F; Macedo, Camila; Hamm, David E et al. (2018) High PD-L1/CD86 MFI ratio and IL-10 secretion characterize human regulatory dendritic cells generated for clinical testing in organ transplantation. Cell Immunol 323:9-18
Rogers, Meredith C; Lamens, Kristina D; Shafagati, Nazly et al. (2018) CD4+ Regulatory T Cells Exert Differential Functions during Early and Late Stages of the Immune Response to Respiratory Viruses. J Immunol 201:1253-1266
Chen, Ruochan; Zhu, Shan; Fan, Xue-Gong et al. (2018) High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis. Hepatology 67:1823-1841
Jing, Y; Nguyen, M M; Wang, D et al. (2018) DHX15 promotes prostate cancer progression by stimulating Siah2-mediated ubiquitination of androgen receptor. Oncogene 37:638-650
Singh, Krishna B; Ji, Xinhua; Singh, Shivendra V (2018) Therapeutic Potential of Leelamine, a Novel Inhibitor of Androgen Receptor and Castration-Resistant Prostate Cancer. Mol Cancer Ther 17:2079-2090
Butterfield, Lisa H (2018) The Society for Immunotherapy of Cancer Biomarkers Task Force recommendations review. Semin Cancer Biol 52:12-15
Gao, Ying; Tan, Jun; Jin, Jingyi et al. (2018) SIRT6 facilitates directional telomere movement upon oxidative damage. Sci Rep 8:5407
Krishnamurthy, Anuradha; Dasari, Arvind; Noonan, Anne M et al. (2018) Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer. Cancer Res 78:5398-5407
Santos, Patricia M; Butterfield, Lisa H (2018) Next Steps for Immune Checkpoints in Hepatocellular Carcinoma. Gastroenterology 155:1684-1686
Liu, Zuqiang; Ge, Yan; Wang, Haiyan et al. (2018) Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2. Nat Commun 9:4682

Showing the most recent 10 out of 1187 publications